(ANSA) - ROME, MAY 13 - The simple prescription of an anti-inflammatory drug (for example a cortisone) at the time of discharge could halve the risk of long-term death for those who have passed a SARS-CoV-2 infection form , whose risk of dying within one year of hospitalization is on average more than double.
This is suggested by a study published in the journal Frontiersin Medicine and conducted at the University of Florida: experts have revealed that covid patients who during hospitalization have reached higher levels of inflammation (measurable on the basis of the concentration of a molecule in the blood, the C reactive protein) , are those most at risk of death from any cause, in the year following hospitalization.
The same researchers in previous work had found that patients admitted with severe form of dicovid had a more than doubled risk of death for the full year following admission, compared to individuals who took moderate or mild covid.
In this new study, US experts showed in a group of 1207 patients hospitalized for covid that those with higher levels of C-reactive protein during hospitalization had a 61% greater risk of dying (from any cause for the entire first year after discharge) than patients. who had low levels of C reactive protein during hospitalization.
The hypothesis of the clinicians is that the high levels of inflammation reached by the organism of the patients during the acute infection persist over time even after healing, increasing the risk of death of the cured person for the whole year following hospitalization.
(HANDLE).
